Pelago Bioscience

Company-provided description, not an official-source fact. Certifications, capacities, years and market positions stated in it are the company's own claims until a record below confirms them.

Pelago Bioscience AB 由首席执行官 Michael Dabrowski 于 2013 年在 Science(2013 年)上发表原始 CETSA 方法论后创立,该方法引入了……

Type
manufacturer (our classification of the record, not a statement by the company)
Role
Manufacturer (official record)
Location
Sweden
Website
http://www.pelagobio.com
Categories
药品制造

Listed in a source registry

PharmaSource directory

What is established and what is not

No researcher review has been written for this company yet. 4 official records from 3 official sources are on file. 5 other entries are not official records: our own technical checks and searches, open directory listings, our inferences or the company's own statements. Everything is listed below with its evidence type: each entry confirms only what it literally says; none of them is a review. The manufacturing role above rests on the official records listed below, and only as far as each literally goes: a facility registration or licence is not an observation of current production. Nothing here confirms ownership or trading status beyond what each record literally says.

Facts on file, each with its evidence type

Import rules for these goods

Product-specific import rules not established for the catalog category 药品制造: neither the company's own description nor an official activity code shows that its own goods are of this kind. A catalog category alone is our classification, not proof of what the company makes or sells.

Check independently

Full page for humans